FDA approves new pill to reduce pain from endometriosis
TRENTON, N.J. (AP) - U.S. regulators have approved a new treatment for pain caused by endometriosis.
The common condition involves abnormal tissue growth from the uterus that can cause pain and infertility.
Drugmaker Abbvie said Tuesday that the Food and Drug Administration approved its drug, Orilissa, for pain during menstruation and at other times. The company says it's the first new pill for endometriosis in a decade.
In testing, it significantly reduced menstrual pain in about 45 percent of women given a low dose and 75 percent given a high dose, compared to about 20 percent of women given dummy pills.
The drug works by reducing production of the hormone estrogen. That caused side effects in some participants, including hot flashes and bone thinning.
Orilissa will cost $845 every four weeks without insurance.
Desktop NewsClick to open Continuous News in a sidebar that updates in real-time.
Officer shot, killed in Mandeville was former Marine; leaves behind 7 children
East Baton Rouge on track to break record number of overdose deaths
FEMA issues Livingston Parish deadline for flood prevention master plan
Zachary man drowns while attempting elaborate marriage proposal in Tanzania
Police officer dead, another injured after shooting in Mandeville
Southern Center Jaylon Brinson excited to play in front of home town
Fans' Choice Award Winner 2019: Week 1- Isaiah Jones
Coach O Postgame after Lsu defeats Texas 45-38
Hunter Register leads Southern's offense despite loss to McNeese
Taylor Bannister's journey to becoming a LSU Volleyball Superstar